Managed Healthcare Executive14h
For Opzelura, Positive Results from One Trial, Less So From Another | AAD 2025
The ruxolitinib cream met its primary end point as a treatment for prurigo nodularis in one phase 3 trial but fell short in ...
Managed Healthcare Executive21h
Analysis Finds Opzelura Not Associated with Cancer or Cardiovascular Events
In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...
Ozempic vs Metformin For Weight Loss: Weighing the Pros & Cons of Each
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Anchorage Daily News22h
Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of ...
Opinion
MyNorthwest1dOpinion
Rantz: Sen. Patty Murray tried to call out FDA nominee, gets schooled instead
Sen. Patty Murray advocates for transparency but faces unexpected challenges during the FDA nominee hearing for her double standard.
Lebron James and Silicon Valley’s elite use hyperbaric oxygen therapy to stall aging and inflammation. Here’s what it’s all about
The body’s tissues need oxygen to function. Hyperbaric oxygen therapy in a medical-grade, FDA-approved chamber allows you to ...
Drug Delivery Business1d
Dexcom receives FDA warning letter
Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...
MedPage Today1d
FDA Approves Ocular Implant for Vision-Threatening MacTel
The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Travere Therapeutics: Tricky Outlook Gives Me Pause For Thought - Downgrade
Travere Therapeutics' Filspari boosts revenue with FDA approval, but heavy losses and competitive threats raise concerns for ...
Targeted Oncology1d
FDA Clears Phase 1 Trial of MRANK-106 in Advanced Solid Tumors
The FDA cleared the investigational new drug application for MRANK-106, a dual WEE1/YES1 kinase inhibitor, targeting advanced ...
California biotech company gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...